Terms: = Skin cancer AND ETV4, PEA3, 2118, ENSG00000175832, E1AF, E1A-F, PEAS3
20 results:
1. Immunophenotyping characteristics and outcome of COVID-19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir.
Sun Y; Dian Y; Gao Q; Deng G
Front Immunol; 2023; 14():1227905. PubMed ID: 37799722
[TBL] [Abstract] [Full Text] [Related]
2. Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study.
Deng G; Li D; Sun Y; Jin L; Zhou Q; Xiao C; Wu Q; Sun H; Dian Y; Zeng F; Pan P; Shen M
J Med Virol; 2023 Apr; 95(4):e28756. PubMed ID: 37185838
[TBL] [Abstract] [Full Text] [Related]
3. Financial Toxicities Persist for cancer Survivors Irrespective of Current cancer Status: An Analysis of Medical Expenditure Panel Survey.
Karim MA; Talluri R; Shastri SS; Kum HC; Shete S
Cancer Res Commun; 2022 Oct; 2(10):1119-1128. PubMed ID: 36531523
[TBL] [Abstract] [Full Text] [Related]
4. Identification of fusions with potential clinical significance in melanoma.
Moran JMT; Le LP; Nardi V; Golas J; Farahani AA; Signorelli S; Onozato ML; Foreman RK; Duncan LM; Lawrence DP; Lennerz JK; Dias-Santagata D; Hoang MP
Mod Pathol; 2022 Dec; 35(12):1837-1847. PubMed ID: 35871080
[TBL] [Abstract] [Full Text] [Related]
5. Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma.
Wouters J; Kalender-Atak Z; Minnoye L; Spanier KI; De Waegeneer M; Bravo González-Blas C; Mauduit D; Davie K; Hulselmans G; Najem A; Dewaele M; Pedri D; Rambow F; Makhzami S; Christiaens V; Ceyssens F; Ghanem G; Marine JC; Poovathingal S; Aerts S
Nat Cell Biol; 2020 Aug; 22(8):986-998. PubMed ID: 32753671
[TBL] [Abstract] [Full Text] [Related]
6. Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma.
Gupta A; Towers C; Willenbrock F; Brant R; Hodgson DR; Sharpe A; Smith P; Cutts A; Schuh A; Asher R; Myers K; Love S; Collins L; Wise A; Middleton MR; Macaulay VM
Br J Cancer; 2020 Feb; 122(4):506-516. PubMed ID: 31839677
[TBL] [Abstract] [Full Text] [Related]
7. "Cyst" on the forearm of a 28-year-old female: Case report of a CIC-rearranged sarcoma.
Lehane F; Tsikleas G; Bettington A; Limarporn K; Wilkinson L; Lehane K
J Cutan Pathol; 2019 Aug; 46(8):599-602. PubMed ID: 30989672
[TBL] [Abstract] [Full Text] [Related]
8. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M
Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617
[TBL] [Abstract] [Full Text] [Related]
9. COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.
Xie Y; Cao Z; Wong EW; Guan Y; Ma W; Zhang JQ; Walczak EG; Murphy D; Ran L; Sirota I; Wang S; Shukla S; Gao D; Knott SR; Chang K; Leu J; Wongvipat J; Antonescu CR; Hannon G; Chi P; Chen Y
J Clin Invest; 2018 Apr; 128(4):1442-1457. PubMed ID: 29360641
[TBL] [Abstract] [Full Text] [Related]
10. Surgical site infection reduction bundle in patients with gynecologic cancer undergoing colon surgery.
Schiavone MB; Moukarzel L; Leong K; Zhou QC; Afonso AM; Iasonos A; Roche KL; Leitao MM; Chi DS; Abu-Rustum NR; Zivanovic O
Gynecol Oncol; 2017 Oct; 147(1):115-119. PubMed ID: 28734498
[TBL] [Abstract] [Full Text] [Related]
11. Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma.
Lim SY; Menzies AM; Rizos H
Cancer; 2017 Jun; 123(S11):2118-2129. PubMed ID: 28543695
[TBL] [Abstract] [Full Text] [Related]
12. Integration of zebrafish fin regeneration genes with expression data of human tumors in silico uncovers potential novel melanoma markers.
Hagedorn M; Siegfried G; Hooks KB; Khatib AM
Oncotarget; 2016 Nov; 7(44):71567-71579. PubMed ID: 27689402
[TBL] [Abstract] [Full Text] [Related]
13. miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1.
Cohen R; Greenberg E; Nemlich Y; Schachter J; Markel G
Oncotarget; 2015 Aug; 6(22):19006-16. PubMed ID: 26158900
[TBL] [Abstract] [Full Text] [Related]
14. The spectrum of grossly visible pigmented lesions in the uterine cervix: a prospective study.
Tran TA; Niu G; Tomasello CA; Tran HV; Ross JS; Carlson JA
Int J Gynecol Pathol; 2014 Jan; 33(1):89-99. PubMed ID: 24300541
[TBL] [Abstract] [Full Text] [Related]
15. ERK/p90(RSK)/14-3-3 signalling has an impact on expression of pea3 Ets transcription factors via the transcriptional repressor capicúa.
Dissanayake K; Toth R; Blakey J; Olsson O; Campbell DG; Prescott AR; MacKintosh C
Biochem J; 2011 Feb; 433(3):515-25. PubMed ID: 21087211
[TBL] [Abstract] [Full Text] [Related]
16. Genomic characterization of a novel human papillomavirus (HPV-117) with a high viral load in a persisting wart.
Köhler A; Gottschling M; Förster J; Röwert-Huber J; Stockfleth E; Nindl I
Virology; 2010 Mar; 399(1):129-133. PubMed ID: 20096912
[TBL] [Abstract] [Full Text] [Related]
17. The changing face of dermatological practice: 25 years' experience.
Benton EC; Kerr OA; Fisher A; Fraser SJ; McCormack SK; Tidman MJ
Br J Dermatol; 2008 Aug; 159(2):413-8. PubMed ID: 18565175
[TBL] [Abstract] [Full Text] [Related]
18. Expression of e1af, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
Hata H; Kitamura T; Higashino F; Hida K; Yoshida K; Ohiro Y; Totsuka Y; Kitagawa Y; Shindoh M
Oncol Rep; 2008 May; 19(5):1093-8. PubMed ID: 18425363
[TBL] [Abstract] [Full Text] [Related]
19. Cutaneous uretero-ureterostomy: a technique of urinary diversion for high-risk patients with bladder cancer.
Shafik A; Shafik IA; El Sibai O
Surg Technol Int; 2007; 16():151-5. PubMed ID: 17429783
[TBL] [Abstract] [Full Text] [Related]
20. c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.
Wernert N; Raes MB; Lassalle P; Dehouck MP; Gosselin B; Vandenbunder B; Stehelin D
Am J Pathol; 1992 Jan; 140(1):119-27. PubMed ID: 1370594
[TBL] [Abstract] [Full Text] [Related]
